CardioLogs ECG Analysis Platform vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CardioLogs (acquired by Philips in 2021)
VS
by Volta Medical

AI Verdict

CardioLogs ECG Analysis Platform focuses on AI-powered ECG analysis for arrhythmia detection and diagnosis across various cardiac monitoring devices, suitable for general cardiology and emergency medicine. In contrast, VX1+ is an AI-powered software designed to assist electrophysiologists in real-time during cardiac ablation procedures by identifying abnormal electrograms. While both address cardiac rhythm issues, they serve distinct phases of patient care and utilize different data types, making them adjacent rather than direct competitors.

Choose CardioLogs ECG Analysis Platform if…

Choose CardioLogs ECG Analysis Platform if your practice requires a versatile, cloud-based solution for rapid and accurate AI-powered analysis of ECG data from a broad spectrum of cardiac monitoring devices, including Holters and smartwatches. This platform is ideal for general cardiologists, emergency medicine, or internal medicine specialists focused on efficient arrhythmia detection and diagnosis from recorded data.

View CardioLogs ECG Analysis Platform →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist seeking real-time, AI-driven guidance specifically during cardiac ablation procedures for atrial fibrillation or atrial tachycardia. This specialized software integrates with existing EP recording and 3D mapping systems to assist in the precise identification of abnormal electrograms, directly enhancing intra-procedural decision-making and ablation targeting.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CardioLogs ECG Analysis Platform VX1+
Deployment Cloud-based Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs emphasizes a user-friendly, cloud-based platform that streamlines ECG analysis and integrates with EHR systems, leading to significant time savings for clinicians [3, 5, 14]. While VX1+ also features a simple user interface for real-time procedural guidance, CardioLogs' broader accessibility and explicit benefits for diagnostic workflow efficiency give it an edge in overall usability.

Clinical Value

VX1+

Both tools demonstrate strong clinical value with FDA clearance and supporting studies. CardioLogs significantly reduces false positives and analysis time for ECG diagnostics [2, 5]. However, VX1+ provides real-time AI guidance during complex cardiac ablation procedures, standardizing outcomes across operators and centers and showing promising acute and long-term freedom from atrial arrhythmias [8, 9, 10].

Pricing & Value

CardioLogs ECG Analysis Platform

Tool A, CardioLogs, offers more transparency by stating its pricing model as 'Pay per ECG regardless of the number of users,' even though a customized quote requires contacting sales. Tool B, VX1+, provides no public pricing information or details, making its cost structure entirely opaque.

Enterprise Readiness

CardioLogs ECG Analysis Platform

CardioLogs is a cloud-based SaaS solution with explicit EHR integration via Philips IntelliBridge, ISO/IEC 27001 certified AWS servers for secure hosting, and HIPAA compliance [20]. Being a Philips solution further solidifies its enterprise backing. While VX1+ integrates with existing EP lab systems, CardioLogs demonstrates a more comprehensive and explicitly certified enterprise-grade infrastructure.

Innovation

VX1+

Both are highly innovative. CardioLogs was the first FDA-approved AI for ECG analysis and offers vendor-neutral, multi-device compatibility for diagnostics [6]. However, VX1+'s real-time AI guidance during complex, high-stakes cardiac ablation procedures, assisting electrophysiologists in identifying abnormal electrograms, represents a more specialized and transformative application of AI in an interventional setting.

Support & Docs

CardioLogs ECG Analysis Platform

CardioLogs explicitly mentions technical support available directly through its platform's 'Help' menu and provides various documentation like brochures and white papers [5, 6]. While VX1+ offers user manuals, the explicit in-platform support channel and the robust backing of Philips for CardioLogs suggest a more comprehensive and accessible support and documentation ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CardioLogs ECG Analysis Platform VX1+
Product Name CardioLogs ECG Analysis Platform VX1+
Company Cardiologs Technologies (now part of Philips) Volta Medical
Primary Use Case AI and cloud-based analysis of ECG data from various cardiac monitoring devices for rapid, accurate, and efficient arrhythmia detection and diagnosis. AI-powered software assisting electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Target Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology
Core AI Functionality AI-Powered ECG Analysis (Deep Neural Networks), Automated Arrhythmia Detection (e.g., AFib, VT). Real-time manual or automatic annotation of 3D anatomical and electrical maps, Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures.
Compatibility / Integration Multi-Device Compatibility (Holter, smartwatches, ECG patches), Integration with EHR Systems. Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system).

Videos

Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CardioLogs ECG Analysis Platform (Tool A) is designed for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices to aid physicians in arrhythmia detection and diagnosis. VX1+ (Tool B) is AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
CardioLogs ECG Analysis Platform (Tool A) is compatible with ECG data from various cardiac monitoring devices, including Holter monitors, smartwatches, and ECG patches. VX1+ (Tool B) integrates with existing 510(k)-cleared catheters and specific data acquisition systems such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.
CardioLogs ECG Analysis Platform (Tool A) is designed for Cardiology, Emergency Medicine, and Internal Medicine. VX1+ (Tool B) is specifically tailored for electrophysiologists within Cardiology.
Yes, both tools offer real-time capabilities, but for different purposes. CardioLogs ECG Analysis Platform (Tool A) provides real-time monitoring and analysis of ECG data for arrhythmia detection. VX1+ (Tool B) assists electrophysiologists with real-time identification and annotation of abnormal electrograms during cardiac ablation procedures.
AI Tool Finder
AI-powered search. Results may not be comprehensive.